Astrana Health, Inc.
ASTH
$23.18
$0.140.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 490.49% | 11.56% | |||
| Total Other Revenue | 44.25% | 5.53% | |||
| Total Revenue | 46.00% | 5.55% | |||
| Cost of Revenue | 48.89% | 5.06% | |||
| Gross Profit | 24.65% | 9.31% | |||
| SG&A Expenses | 2.69% | 19.38% | |||
| Depreciation & Amortization | 125.88% | 0.80% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 46.03% | 6.03% | |||
| Operating Income | 45.08% | -7.50% | |||
| Income Before Tax | -66.29% | 75.19% | |||
| Income Tax Expenses | -30.49% | 95.36% | |||
| Earnings from Continuing Operations | -89.46% | 64.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 11.22% | -268.37% | |||
| Net Income | -96.04% | 40.81% | |||
| EBIT | 45.08% | -7.50% | |||
| EBITDA | 65.57% | -5.53% | |||
| EPS Basic | -96.03% | 38.74% | |||
| Normalized Basic EPS | 0.66% | 29.68% | |||
| EPS Diluted | -96.00% | 37.58% | |||
| Normalized Diluted EPS | 0.66% | 29.98% | |||
| Average Basic Shares Outstanding | 0.06% | 1.48% | |||
| Average Diluted Shares Outstanding | 0.01% | 1.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -0.90% | |||